105 related articles for article (PubMed ID: 12429526)
1. The mechanism of inhibition of HIV-1 env-mediated cell-cell fusion by recombinant cores of gp41 ectodomain.
Markosyan RM; Ma X; Lu M; Cohen FS; Melikyan GB
Virology; 2002 Oct; 302(1):174-84. PubMed ID: 12429526
[TBL] [Abstract][Full Text] [Related]
2. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.
Lu L; Tong P; Yu X; Pan C; Zou P; Chen YH; Jiang S
Biochim Biophys Acta; 2012 Dec; 1818(12):2950-7. PubMed ID: 22867851
[TBL] [Abstract][Full Text] [Related]
4. ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.
Yu F; Lu L; Liu Q; Yu X; Wang L; He E; Zou P; Du L; Sanders RW; Liu S; Jiang S
Biochim Biophys Acta; 2014 May; 1838(5):1296-305. PubMed ID: 24388952
[TBL] [Abstract][Full Text] [Related]
5. The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region.
Louis JM; Baber JL; Clore GM
Biochemistry; 2015 Nov; 54(45):6796-805. PubMed ID: 26506247
[TBL] [Abstract][Full Text] [Related]
6. Conserved salt bridge between the N- and C-terminal heptad repeat regions of the human immunodeficiency virus type 1 gp41 core structure is critical for virus entry and inhibition.
He Y; Liu S; Li J; Lu H; Qi Z; Liu Z; Debnath AK; Jiang S
J Virol; 2008 Nov; 82(22):11129-39. PubMed ID: 18768964
[TBL] [Abstract][Full Text] [Related]
7. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41.
Bewley CA; Louis JM; Ghirlando R; Clore GM
J Biol Chem; 2002 Apr; 277(16):14238-45. PubMed ID: 11859089
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation.
Markosyan RM; Cohen FS; Melikyan GB
Mol Biol Cell; 2003 Mar; 14(3):926-38. PubMed ID: 12631714
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides.
Malashkevich VN; Chan DC; Chutkowski CT; Kim PS
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9134-9. PubMed ID: 9689046
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
11. Identification of critical antibody-binding sites in the HIV-1 gp41 six-helix bundle core as potential targets for HIV-1 fusion inhibitors.
Li J; Chen X; Huang J; Jiang S; Chen YH
Immunobiology; 2009; 214(1):51-60. PubMed ID: 19159827
[TBL] [Abstract][Full Text] [Related]
12. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
Korazim O; Sackett K; Shai Y
J Mol Biol; 2006 Dec; 364(5):1103-17. PubMed ID: 17045292
[TBL] [Abstract][Full Text] [Related]
13. Buried polar interactions and conformational stability in the simian immunodeficiency virus (SIV) gp41 core.
Ji H; Bracken C; Lu M
Biochemistry; 2000 Feb; 39(4):676-85. PubMed ID: 10651632
[TBL] [Abstract][Full Text] [Related]
14. Chemoenzymatic synthesis of HIV-1 gp41 glycopeptides: effects of glycosylation on the anti-HIV activity and alpha-helix bundle-forming ability of peptide C34.
Wang LX; Song H; Liu S; Lu H; Jiang S; Ni J; Li H
Chembiochem; 2005 Jun; 6(6):1068-74. PubMed ID: 15883971
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
Gallo SA; Puri A; Blumenthal R
Biochemistry; 2001 Oct; 40(41):12231-6. PubMed ID: 11591141
[TBL] [Abstract][Full Text] [Related]
16. Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat.
Izumi K; Nakamura S; Nakano H; Shimura K; Sakagami Y; Oishi S; Uchiyama S; Ohkubo T; Kobayashi Y; Fujii N; Matsuoka M; Kodama EN
Antiviral Res; 2010 Aug; 87(2):179-86. PubMed ID: 20438763
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41.
Soonthornsata B; Tian YS; Utachee P; Sapsutthipas S; Isarangkura-na-Ayuthaya P; Auwanit W; Takagi T; Ikuta K; Sawanpanyalert P; Kawashita N; Kameoka M
Virology; 2010 Sep; 405(1):157-64. PubMed ID: 20580393
[TBL] [Abstract][Full Text] [Related]
18. Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178.
Wexler-Cohen Y; Johnson BT; Puri A; Blumenthal R; Shai Y
J Biol Chem; 2006 Apr; 281(14):9005-10. PubMed ID: 16455666
[TBL] [Abstract][Full Text] [Related]
19. The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.
Abrahamyan LG; Mkrtchyan SR; Binley J; Lu M; Melikyan GB; Cohen FS
J Virol; 2005 Jan; 79(1):106-15. PubMed ID: 15596806
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.
Abrahamyan LG; Markosyan RM; Moore JP; Cohen FS; Melikyan GB
J Virol; 2003 May; 77(10):5829-36. PubMed ID: 12719576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
